Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo consortium

Circulation: Cardiovascular Genetics

Volumn 6, Issue 1, 2013, Pages 73-81

  Mäkelä, Kari Matti ^a   Seppälä, Ilkka ^b   Hernesniemi, Jussi A ^b   Lyytikäinen, Leo Pekka ^b   Oksala, Niku ^b   Kleber, Marcus E ^b   Scharnagl, Hubert ^b   Grammer, Tanja B ^b   Baumert, Jens ^b   Thorand, Barbara ^b   Jula, Antti ^b   Hutri Kähönen, Nina ^b   Juonala, Markus ^b   Laitinen, Tomi ^b   Laaksonen, Reijo ^b   Karhunen, Pekka J ^b   Nikus, Kjell C ^b   Nieminen, Tuomo ^b   Laurikka, Jari ^b   Kuukasjärvi, Pekka ^b   Tarkka, Matti ^b   Viik, Jari ^b   Klopp, Norman ^b   Illig, Thomas ^b   Kettunen, Johannes ^b   Ahotupa, Markku ^b   Viikari, Jorma S A ^b   Kähönen, Mika ^b   Raitakari, Olli T ^b   Karakas, Mahir ^b   Koenig, Wolfgang ^b   Boehm, Bernhard O ^b   Winkelmann, Bernhard R ^b   März, Winfried ^b   Lehtimäki, Terho ^b   more..

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Atherosclerosis; Coronary artery disease; Genome wide association study; Lipoproteins; Oxidative stress

Indexed keywords

APOLIPOPROTEIN B; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84878104581     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.964965     Document Type: Review

References (26)

1. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24-38.
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
3. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation. 2008;118:75-83.
4. Raitakari OT, Juonala M, Rönnemaa T, Keltikangas-Järvinen L, Räsänen L, Pietikäinen M, et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol. 2008;37:1220-1226.
5. Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, et al LURIC Study Group (Ludwigshafen RIsk and Cardiovascular Health). Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics. 2001;2(Suppl 1):S1-S73.
6. Thorand B, Schneider A, Baumert J, Doring A, Marowsky-Koppl M, Heier M, et al. Case-cohort studies: an effective design for the investigation of biomarkers as risk factors for chronic diseases-demonstrated by the example of the MONICA/KORA Augsburg Case-Cohort Study 1984-2002. Gesundheitswesen. 2005;67(Suppl 1):S98-S102.
7. Löwel H, Döring A, Schneider A, Heier M, Thorand B, Meisinger C; MONICA/KORA Study Group. The MONICA Augsburg surveys- basis for prospective cohort studies. Gesundheitswesen. 2005;67(Suppl 1):S13-S18.
8. Nieminen T, Lehtinen R, Viik J, Lehtimäki T, Niemelä K, Nikus K, et al. The Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality. BMC Cardiovasc Disord. 2006;6:9.
9. Raitoharju E, Seppälä I, Levula M, Kuukasjärvi P, Laurikka J, Nikus K, et al. Common variation in the ADAM8 gene affects serum sADAM8 concentrations and the risk of myocardial infarction in two independent cohorts. Atherosclerosis. 2011;218:127-133.
10. Mennander A, Kuukasjärvi P, Laurikka J, Nikus K, Karhunen PJ, Tarkka M, et al. Diagnostic performance of plasma high sensitive Creactive protein in detecting three-vessel coronary artery disease: modification by apolipoprotein E genotype. Scand J Clin Lab Invest. 2008;68:714-719.
11. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:100-107.
12. Ahotupa M, Marniemi J, Lehtimäki T, Talvinen K, Raitakari OT, Vasankari T, et al. Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem. 1998;31:257-261.
13. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816-834.
14. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3:e3583.
15. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
17. Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics. 2010;11:134.
18. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249.
19. Paré G, Chasman DI, Parker AN, Zee RR, Mälarstig A, Seedorf U, et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet. 2009;2:142-150.
20. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336-2337.
21. Homma Y, Michishita I, Hayashi H, Shigematsu H; Kanagawa Lipid Research Group. Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultracentrifugally separated low-density lipoprotein subfractions: 12-month, open-label trial. J Atheroscler Thromb. 2010;17:1049-1053.
22. Kumar V, Butcher SJ, Öörni K, Engelhardt P, Heikkonen J, Kaski K, et al. Three-dimensional cryoEM reconstruction of native LDL particles to 16Å resolution at physiological body temperature. PLoS ONE. 2011;6:e18841.
23. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
24. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, Clarke R, et al. Fortythree loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 2009;5:e1000730.
25. Wojczynski MK, Gao G, Borecki I, Hopkins PN, Parnell L, Lai CQ, et al. Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res. 2010;51:3316-3323.
26. Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? J Am Coll Cardiol. 2006;48:973-979.